How we approach hemangiomas in infants
- PMID: 34151510
- DOI: 10.1002/pbc.29077
How we approach hemangiomas in infants
Abstract
Pediatric oncologists are increasingly involved in the management of benign vascular tumors and their associated life-threatening complications. Hemangiomas are the most common referring diagnosis to multidisciplinary vascular anomalies clinics. However, as contemporary research has revealed, hemangiomas are not a single, easily defined entity but rather a diverse set of related vascular tumors, each having a unique natural history, growth pattern, and response to therapy. This manuscript seeks to illustrate how we evaluate and manage these complex tumors, their complications, and associated syndromes, while remaining ever vigilant for malignant hemangioma mimickers such as soft tissue sarcomas and congenital leukemia.
Keywords: LUMBAR syndrome; PHACES; hemangioma; propranolol; timolol; vascular tumor.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85-94.
-
- Krowchuk DP, Frieden IJ, Mancini AJ, et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019;143(1):e20183475.
-
- Seiffert A, Schneider M, Roessler J, Larisch K, Pfeiffer D. Incidence, treatment patterns, and health care costs of infantile hemangioma: results of a retrospective German database analysis. Pediatr Dermatol. 2017;34(4):450-457.
-
- Anderson KR, Schoch JJ, Lohse CM, Hand JL, Davis DM, Tollefson MM. Increasing incidence of infantile hemangiomas (IH) over the past 35 years: correlation with decreasing gestational age at birth and birth weight. J Am Acad Dermatol. 2016;74(1):120-126.
-
- Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol. 2008;25(2):168-173.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical